Biosimilars encircle Rituxan, US debates innovator exclusivity | Nature Biotechnology
Home - TRUXIMA® (rituximab-abbs) HCP site.
Teva/Celltrion's Truxima Is First Biosimilar Rituxan To Reach US Market :: Scrip
FDA panel unanimously backs Celltrion's Rituxan biosimilar | Fierce Pharma
Teva launches biosimilar to Roche's Rituxan
About Biosimilars - TRUXIMA® (rituximab-abbs)
The U.S. Biosimilars Market: Shaking The “Laggard” Label | Contract Pharma
Biosimilars 2020 Year in Review | Fish & Richardson - JDSupra
Teva settles with Roche to launch first Rituxan biosimilar in US - BioProcess InternationalBioProcess International
Teva: Biosimilars In The US Will Become Like Complex Generics :: Generics Bulletin
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S. | Fierce Pharma
Teva and Celltrion Launch Truxima (biosimilar- rituximab) to Treat Wegener's Granulomatosis and Microscopic Polyangiitis in the US
Celltrion's Truxima (rituximab-abbs) Biosimilar Product Profile
Pfizer's rituximab biosimilar gets late-stage trial boost
Roche faces prospect of second Rituxan biosimilar in US - PMLiVE
Teva teams with Celltrion in $160m biosimilar deal - Globes
Roche's patent cliff just got steeper as FDA approves Celltrion's Rituxan biosimilar Truxima | Fierce Pharma
Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States | Business Wire
Celltrion and Teva announce first Rituxan biosimilar approval in US
Global Rituximab Biosimilar Market Assessment –Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast 2019- 2027 | Medgadget
Teva launches rituximab biosimilar Truxima in US
Are biosimilars the next frontier in drug development? - STAT
Top developments in biosimilars during 2019 - GaBI Journal
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership - Drug Discovery and Development
Teva teams up on biosims with Celltrion three years after its Lonza JV divorce | Fierce Biotech
Teva Pharmaceuticals 63459010450 - McKesson Medical-Surgical
The First Rituxan Biosimilar Is Expected to Be Approved by FDA – Creative Biolabs rAb Blog
Teva launches Rituxan biosimilar for Rheumatoid Arthritis - Globes
Drug Channels: The Booming Biosimilar Market of 2020
